RE: A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer30 Apr 2023 23:25
Ahfam i really hope youre right, you and so many on here have been invested 12+ years, me personally since 2018. If were right and the science is sound, the current SP will be long gone soon, and, more importantly than all of us making a few quid, patients will start to benefit. Come on 1801/2 and 737 !!